AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND SANTOSH KESARIAgreement by And • June 30th, 2015 • Regen BioPharma Inc • Pharmaceutical preparations • California
Agreement by and between Santosh Kesari (“Consultant”) , a natural person whose address is at 3525 Del Mar Heights Road #133, San Diego CA 92130 and Regen Biopharma, Inc. (“Company”) , a Nevada corporation whose address is 4700 Spring Street, St 304, La Mesa, California 91942.
Law Offices of Joseph L. PitteraRegen BioPharma Inc • June 30th, 2015 • Pharmaceutical preparations
In connection with the Registration Statement on Form S-8 (the “Registration Statement”) of Regen Biopharma, Inc., a Nevada corporation (the “Company”), filed with the Securities and Exchange Commission pursuant to the Securities Act of 1933, as amended (the “Act”), and the rules and regulations thereunder (the “Rules”), you have asked me to furnish my opinion as to the legality of the securities being registered under the Registration Statement. The Registration Statement relates to the registration under the Act of 206,121 shares of the Company’s common stock, par value $0.0001 per share to be issued pursuant to the Agreement by and between Regen Biopharma, Inc. and Santosh Kasari (“Agreement”). Common shares to be issued pursuant to the Agreement may be collectively referred to as “Shares”.
